The latest vaccination schedule was published at the beginning of October 2024 by the ministry. As every year, it includes recommendations intended to adjust the vaccination policy of which private nurses are effectors in their own right just as they are essential players in prevention. Update on what’s new.
Vaccination against pneumococcal infections
• The new 15-valent conjugate vaccine Vaxneuvance® has been integrated into the strategy for preventing pneumococcal infections in infants and people aged under 18 years. When it becomes available and supported, the 15-valent conjugate vaccine Vaxneuvance® and the 13-valent conjugate vaccine Prevenar13® may be used interchangeably, particularly as part of the compulsory vaccination of infants born since 1is January 2018.
• In adults, the integration into the vaccination schedule of the new 20-valent conjugate vaccine Prevenar 20®, with a single dose vaccination schedule, makes it possible to simplify the vaccination schedule currently in force.
Vaccination against invasive meningococcal infections
• Tetravalent ACWY vaccination is recommended in infants according to a two-dose vaccination schedule (one dose at the age of 6 months followed by one dose at the age of 12 months), with the Nimenrix® vaccine; and in adolescents aged 11 to 14 years, in a one-dose schedule, regardless of their vaccination status.
• A catch-up vaccination against ACWY meningococci is recommended for people aged 15 to 24 years. These recommendations can be implemented as soon as vaccines are covered under common law.
• Please note that compulsory vaccination against serogroups ACWY and B in infants will come into force on 1is January 2025.
Vaccination against RSV infections
• To protect newborns and infants under 6 months of age, vaccination against RSV, with the Abrysvo vaccine, is recommended for pregnant women between 32e and the 36e week of amenorrhea, before the epidemic period and until the end of this period.
• Vaccination against RSV, with the Abrysvo vaccine or the Arexvy vaccine, is recommended for all people aged 75 and over, and for people aged 65 and over, with chronic respiratory or cardiac pathology and susceptible to be a victim of decompensation during an RSV infection.
Mpox vaccination
• Implementation of a reactive vaccination campaign is recommended, using third generation smallpox and Mpox vaccines (Imvanex® and Jynneos®). These vaccines are not marketed in France and are subject to a specific distribution procedure. The people targeted by this vaccination campaign depend on the level of epidemic threat.
Shingles Vaccination
• The Shingrix® vaccine is now integrated into the shingles vaccination strategy. It is recommended (only with a two-dose regimen) in immunocompromised adults aged 18 and over.
• Preferential use of this vaccine is also recommended for people aged 65 and over, again at a rate of two doses.
• The same goes for those who have a history of shingles or have been previously vaccinated with the Zostavax® vaccine within at least one year after vaccination or illness.
These recommendations can be implemented as soon as the Shingrix® vaccine is covered under common law.
New vaccine
• This is Shingrix® which is a recombinant shingles vaccine with adjuvant.
Measles vaccination
• To ensure better protection, an additional dose of MMR (measles-mumps-rubella) vaccine is recommended for people born after 1980 and who received a first vaccination before the age of one.
Marketing stoppages
They concern the vaccines Imovax Polio® (against polio), Efluelda (against the flu), Revaxis ® (against diphtheria, tetanus and poliomyelitis) and Zostavax (against shingles).
The electronic vaccination record now on My health space
As a reminder, since 2022, the electronic vaccination record has been included in the digital health space My health space. It allows professionals and users alike to provide information on vaccinations carried out and to know the next vaccinations planned according to their age.
To download the official vaccination schedule, scan this QRCode or click here:
https://sante.gouv.fr/IMG/pdf/calendrier_vaccinal_oct24.pdf
